Cumberland Pharmaceuticals Inc Investor Relations Material
Latest events
Q4 2023
Cumberland Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cumberland Pharmaceuticals Inc
Access all reports
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, develops, acquires and commercializes prescription products for the treatment of acute pain, gastroenterology, rheumatology and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for direct delivery of azithromycin in combination with amoxicillin and potassium clavulanate to patients with respiratory tract infections caused by H. pylori and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic or hypervolemic hyponatremia; Vibativ (telavancin), which is indicated for the treatment of certain serious bacterial infections involving one or more pathogens caused by Gram-positive microorganisms including methicillin-resistant Staphylococcus aureus (MRSA), as well as complicated skin and skin structure infections caused by Gram-positive microorganisms.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States